| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), KPRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 40.0K | - | - | |
| Dir | 25.0K | - | - | |
| Dir | 25.0K | - | - | |
| Dir | 25.0K | - | - | |
| Dir | 25.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Armistice Capital, LLC56 | 10% Owner | Sell | 260,963 | $2.48 | $646,607.65 | -24.9% | -17.4% | -93.8% | |
| Jul 29, 2021 | Armistice Capital, LLC56 | Director, 10% Owner | Sell | 3,153,138 | $4.61 | $14,546,264.01 | -75.1% | -33.4% | -94.9% | |
| Jan 6, 2021 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 1,531,101 | $5.23 | $8,000,002.73 | +84.3% | - | - | |
| Feb 10, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 23,000 | $6.11 | $140,460.00 | +1.3% | - | - | |
| Dec 6, 2019 | Goldberg Morton | Director | Sell | 1,961 | $6.93 | $13,589.73 | -100% | - | - | |
| Nov 12, 2019 | Goldberg Morton | Director | Sell | 2,001 | $4.29 | $8,584.29 | -50.5% | - | - | |
| Sep 30, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 605,001 | $3.12 | $1,890,613.11 | +50.9% | - | - | |
| Jul 15, 2019 | Mann Brenda | VP Of Research &Development | Sell | 19,049 | $0.24 | $4,503.18 | -9.8% | - | - | |
| Jul 15, 2019 | From Stephen | President And CEO | Sell | 127,355 | $0.24 | $30,106.72 | -11.0% | - | - | |
| Jul 15, 2019 | Wirostko Barbara | Chief Medical Officer | Sell | 19,463 | $0.24 | $4,601.05 | -4.6% | - | - |